Abstract

Editorial FocusProtein kinase C-α comes to the rescue of aquaporin-2Serena M. BagnascoSerena M. BagnascoDepartment of Pathology, The Johns Hopkins School of Medicine, Baltimore, MarylandAddress for reprint requests and other correspondence: S. M. Bagnasco, Clinical Renal Biopsy Service, The Johns Hopkins School of Medicine, Ross 632, 720 Rutland Ave. Baltimore, MD 21205 (e-mail: [email protected]).Search for more papers by this authorPublished Online:01 Jul 2012https://doi.org/10.1152/ajprenal.00225.2012This is the final version - click for previous versionMoreSectionsPDF (218 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat the article by Thai et al. (12) in an issue of the American Journal of Physiology-Renal Physiology brings to the forefront a previously unrecognized role of PKC-α in preventing downregulation of aquaporin (AQP)2 by ANG II.Regulated transport of water, sodium, and urea in the renal medulla is crucial for maintaining a hyperosmolar interstitium to excrete concentrated urine while at the same time adequately retaining water. The main inner medullary water and urea transporters involved in this process are AQP2 and two urea transporters (UTs), UT-A1 and UT-A3, whose abundance and activity play a critical role in water balance. Regulation of these transporters is complex and involves cross-talk among many different factors affecting the urine concentration process.More investigation in this area is necessary to elucidate the individual signaling pathways that confer the regulatory specificity of water and urea transport in distinct settings, and, in this respect, the study by Thai et al. represents a step forward.Among the main factors controlling water and urea transport, ANG II and arginine vasopressin (AVP) have synergistic effects.AVP controls the transcription and expression of AQP2 through increased cAMP and activates PKA-induced phosphorylation of the cAMP-responsive element (CREB), which, in turn, stimulates transcription of the AQP2 gene.ANG II also induces AQP2 gene expression and protein abundance and stimulates its targeting to the apical membrane (8). The exchange protein activated by cAMP (Epac) may be implicated in the long-term control of AQP2 (7).Short-term activation of AQP2 by vasopressin and PKA occurs by phosphorylation at Ser256 with mobilization of AQP2 to the apical membrane. Bioinformatic analysis and some in vitro studies have suggested that other kinases, such as PKG, may participate in AQP2 phosphorylation at different consensus sites (9).Long-term expression of UT-A1 and UT-A3 is controlled at the transcriptional level by hypertonicity through binding of tonicity-responsive enhancer-binding protein (TonEBP) to the first promoter of the Slc14a2 gene (10, 11).Short-term stimulation of urea transport by UT-A1 and UT-A3 involves vasopressin-induced phosphorylation at Ser84 on both transporters (3) and phosphorylation by PKA at Ser486 and Ser499 on UT-A1 (1), resulting in translocation of UT-A1 to the apical membrane. There is also evidence that vasopressin activation of Epac may result in UT-A1 phosphorylation and translocation to the apical membrane mediated by the MEK-ERK pathway (13). Like AQP2, UT-A1 and UT-A3 have various potential phosphorylation consensus sites and could be susceptible to regulation by other kinases and phosphatases.Synergy between ANG II and AVP control of urea transport is exemplified by the finding that ANG II increases AVP-mediated phosphorylation of UT-A1 and urea permeability of the rat inner medullary collecting duct (IMCD) (5).The role of PKC-α in urine concentration has been the focus of a recent study (6) on the short-term regulation of urea transport by hyperosmolarity, stemming from previous findings (2) that hyperosmolarity stimulates urea transport in perfused tubules. Klein et al. (6) showed that activation of UT-A1 by hyperosmolarity is mediated by PKC-α phosphorylation of UT-A1 at one as-yet-undetermined consensus site, different from the Ser486 phosphorylated by PKA. These observations were conducted on isolated terminal IMCDs of rats and mice, including PKC-α-deficient mice, which excrete mildly diluted urine and have reduced abundance of UT-A1 compared with wild-type control mice. In IMCD suspensions from PKC-α-deficient mice, hypertonicity fails to induce UT-A1 phosphorylation, supporting the role of PKC-α in the upregulation of UT-A1 activity.In the study by Thai et al. (12), the authors more specifically investigated the role of PKC as a mediator of ANG II-induced regulation of urea and water transport in the inner medulla.The effect of ANG II was tested in PKC-α-deficient mice, and ANG II increased the excretion of diluted urine in treated PKC-α−/− mice but not in control mice. This finding suggests that PKC is protective toward reduced AQP2 and impairment of urine concentration due to ANG II.The reduced ability of ANG II-treated PKC-α−/− mice to concentrate urine was associated with a decreased abundance of medullary AQP2.The decreased abundance of AQP2 appeared to be caused by decreased gene transcription, resulting from decreased phosphorylation of the transcription factor CREB. While CREB phosphorylation is known to be PKA mediated, these findings suggest that PKC may play a role as well and that PKC-α may affect directly or indirectly CREB phosphorylation downstream of ANG II. Although PKC-α activation of CREB has been previously described in cultured cells (8), it was not tested in vivo before. This study shows that a regulatory coordination exists between PKC-α and PKA.Both AQP2 and UT-A1 are regulated by ANG II. However, although AQP2 was decreased in ANG II-treated PKC-α−/− mice, the abundance of UT-A1 was unchanged, and the abundance and phosphorylation of TonEBP, which controls transcription of UT-A1, was also unchanged.This lack of effect of ANG II on TonEBP and UT-A1 suggests that different pathways mediate ANG II regulation of AQP2 and UT-A1.Since both AQP2 and UT-A1 are regulated by AVP and ANG II, the difference in signaling pathways could be the mechanism that permits specificity in the regulation of water and urea transport.An interesting observation from this study is that ANG II infusion per se did not result in increased AQP2 expression in wild-type mice, which leads to legitimate speculations about the role of other kinases and phosphatases that may be activated in parallel and stabilize the transcriptionally active form of CREB. A recent study (4) has implicated calcineurin in the dephosphorylation of UT-A1 and decreasing its abundance at the apical membrane, indicating that phosphatases may directly affect the activity of water and urea transporters and may potentially influence their degradation and half-life. (Fig. 1).Fig. 1.Schematic illustration of PKC involvement in the regulation of aquaporin-2 (AQP2) and urea transporter UT-A1 by arginine vasopressin (AVP) and ANG II in the inner medullary collecting duct. TonEBP, tonicity-responsive enhancer-binding protein; V2, vasopressin type 2 receptor; AT1, ANG II type 1 receptor.Download figureDownload PowerPointDISCLOSURESNo conflicts of interest, financial or otherwise, are declared by the author(s).AUTHOR CONTRIBUTIONSAuthor contributions: S.M.B. conception and design of research; S.M.B. performed experiments; S.M.B. analyzed data; S.M.B. interpreted results of experiments; S.M.B. prepared figures; S.M.B. drafted manuscript; S.M.B. edited and revised manuscript; S.M.B. approved final version of manuscript.REFERENCES1. Blount MA , Mistry AC , Fröhlich O , Price SR , Chen G , Sands JM , Klein JD. Phosphorylation of UT-A1 urea transporter at serines 486 and 499 is important for vasopressin-regulated activity and membrane accumulation. Am J Physiol Renal Physiol 295: F295–F299, 2008.Link | ISI | Google Scholar2. Gillin AG , Sands JM. Characteristics of osmolarity-stimulated urea transport in the rat IMCD. Am J Physiol Renal Fluid Electrolyte Physiol 262: F1061–F1067, 1992.Link | Google Scholar3. Hwang S , Gunaratne R , Rinschen MM , Yu MJ , Pisitkun T , Hoffert JD , Fenton RA , Knepper MA , Chou CL. Vasopressin increases phosphorylation of Ser84 and Ser486 in Slc14a2 collecting duct urea transporters. Am J Physiol Renal Physiol 299: F559–F567, 2010.Link | ISI | Google Scholar4. Ilori TO , Wang Y , Blount MA , Martin CF , Sands JM , Klein JD. Acute calcineurin inhibition with tacrolimus increases phosphorylated UT-A1. Am J Physiol Renal Physiol 302: F998–F1004, 2012.Link | ISI | Google Scholar5. Kato A , Klein JD , Zhang C , Sands JM. Angiotensin II increases vasopressin-stimulated facilitated urea permeability in rat terminal IMCDs. Am J Physiol Renal Physiol 279: F835–F840, 2000.Link | ISI | Google Scholar6. Klein JD , Martin CF , Kent KJ , Sands JM. Protein kinase C-α mediates hypertonicity-stimulated increase in urea transporter phosphorylation in the inner medullary collecting duct. Am J Physiol Renal Physiol 302: F1098–F1103, 2012.Link | ISI | Google Scholar7. Kortenoeven ML , Trimpert C , Brand MV , Li Y , Wetzels JF , Deen PM. In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB, but may involve Epac. Am J Physiol Renal Physiol 302: F1098–F1103, 2012.Link | ISI | Google Scholar8. Li C , Wang W , Rivard CJ , Lanaspa MA , Summer S , Schrier RW. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol 300: F1255–F1261, 2011.Link | ISI | Google Scholar9. Moeller HB , Olesen ET , Fenton RA. Regulation of the water channel aquaporin-2 by posttranslational modification. Am J Physiol Renal Physiol 300: F1062–F1073, 2011.Link | ISI | Google Scholar10. Nakayama Y , Naruse M , Karakashian A , Peng T , Sands JM , Bagnasco SM. Cloning of the rat Slc14a2 gene and genomic organization of the UT-A urea transporter. Biochim Biophys Acta 1518: 19–26, 2001.Crossref | PubMed | ISI | Google Scholar11. Nakayama Y , Peng T , Sands JM , Bagnasco S. The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression. J Biol Chem 275: 38275–38280, 2000.Crossref | PubMed | ISI | Google Scholar12. Thai TL , Blount MA , Klein JD , Sands JM. Lack of protein kinase C-α leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension. Am J Physiol Renal Physiol; doi:10.1152/ajprenal.00098.2012.ISI | Google Scholar13. Wang Y , Klein JD , Blount MA , Martin CF , Kent KJ , Pech V , Wall SM , Sands JM. Epac regulates UT-A1 to increase urea transport in inner medullary collecting ducts. J Am Soc Nephrol 20: 2018–2024, 2009.Crossref | PubMed | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: S. M. Bagnasco, Clinical Renal Biopsy Service, The Johns Hopkins School of Medicine, Ross 632, 720 Rutland Ave. Baltimore, MD 21205 (e-mail: [email protected]edu). Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByThe Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells—a Potential Target for Pharmacological Intervention in Cardiovascular Diseases11 February 2016 | Frontiers in Pharmacology, Vol. 7The calcium-dependent protein kinase CPK7 acts on root hydraulic conductivity15 December 2014 | Plant, Cell & Environment, Vol. 38, No. 7 More from this issue > Volume 303Issue 1July 2012Pages F35-F36 Copyright & PermissionsCopyright © 2012 the American Physiological Societyhttps://doi.org/10.1152/ajprenal.00225.2012PubMed22535798History Received 19 April 2012 Accepted 22 April 2012 Published online 1 July 2012 Published in print 1 July 2012 Metrics

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call